Results
21
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
21 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ORAD | ₪0.62 | -1.6% | -12.0% | ₪58.2m | n/a | PE8.6x | n/a | n/a | ||
NXSN | ₪69.40 | -0.1% | 98.3% | ₪5.6b | n/a | PE26.3x | n/a | 0.9% | ||
TLSY | ₪182.70 | -1.7% | -28.1% | ₪1.6b | n/a | PE16.5x | n/a | 7.6% | ||
ORTC | ₪9.96 | 11.4% | -30.3% | ₪44.5m | n/a | PS9.2x | n/a | 5.0% | ||
MCRNT | ₪2.88 | 13.4% | 57.7% | ₪27.0m | n/a | PS10.2x | n/a | 0% | ||
EEAM-M | ₪0.10 | 9.7% | -94.2% | ₪10.0m | n/a | PS0.9x | n/a | 1,634.0% | ||
ARD | ₪53.26 | 1.6% | -8.1% | ₪1.3b | n/a | PE15.9x | n/a | 3.2% | ||
UNIT | ₪29.39 | -3.4% | -8.6% | ₪408.6m | n/a | PE9.2x | n/a | 7.8% | ||
DNA | ₪0.87 | -1.0% | 25.7% | ₪107.2m | n/a | PE7.1x | n/a | n/a | ||
CLAB | ₪12.16 | 3.5% | -8.1% | ₪103.1m | n/a | PE6.6x | n/a | n/a | ||
SVRE | ₪0.037 | -7.5% | -94.0% | ₪9.5m | n/a | PS5.5x | E31.8% | n/a | ||
PCBT | ₪8.34 | 3.6% | 125.3% | ₪599.0m | n/a | PE30.6x | n/a | 2.4% | ||
NYAX | ₪124.20 | 3.1% | 48.2% | ₪4.5b | ₪121.29 | PS4.3x | E122.6% | n/a | ||
SNCM | ₪1.38 | 2.7% | 53.8% | ₪299.8m | n/a | PE7.4x | n/a | 6.7% | ||
STG | ₪56.40 | -3.9% | 43.1% | ₪262.3m | n/a | PE13.8x | n/a | 0% | ||
ICON | ₪4.58 | 0.7% | -5.8% | ₪258.6m | n/a | PE8.5x | n/a | 3.9% | ||
ININ | ₪2.56 | 2.9% | 3.0% | ₪112.0m | n/a | PS0.2x | n/a | 0% | ||
FGAS | ₪11.99 | 1.1% | 53.7% | ₪255.1m | n/a | PS7.7x | n/a | n/a | ||
ACCL | ₪1.36 | 0% | 98.2% | ₪219.8m | n/a | PE32.1x | n/a | 0% | ||
HIPR | ₪20.20 | 7.7% | 35.5% | ₪945.8m | n/a | PE15.8x | n/a | 1.8% | ||
INTR | ₪66.42 | 1.0% | 20.7% | ₪134.8m | n/a | PE14.6x | n/a | 0.8% |